Cargando…
The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1
BACKGROUND: Bv8, prokineticin-1, or endocrine gland-vascular endothelial growth factor, and prokineticin-2 are recently isolated peptide agonists of two G protein-coupled receptors, prokineticin receptor-1 (PROKR 1) and PROKR 2, and have been described as affecting a number of myeloid cell functions...
Autores principales: | Franchi, Silvia, Giannini, Elisa, Lattuada, Donatella, Lattanzi, Roberta, Tian, Hui, Melchiorri, Pietro, Negri, Lucia, Panerai, Alberto E, Sacerdote, Paola |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584092/ https://www.ncbi.nlm.nih.gov/pubmed/18957080 http://dx.doi.org/10.1186/1471-2172-9-60 |
Ejemplares similares
-
Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation
por: Lattanzi, Roberta, et al.
Publicado: (2021) -
Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
por: Lattanzi, Roberta, et al.
Publicado: (2022) -
Prokineticin-Receptor Network: Mechanisms of Regulation
por: Lattanzi, Roberta, et al.
Publicado: (2022) -
Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of Diabetes
por: Castelli, Mara, et al.
Publicado: (2016) -
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity
por: Severini, Cinzia, et al.
Publicado: (2015)